Alpha memo: resveratrol / exercise bounded update

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Reframe the synthesis so the contrast is explicitly a species-and-endpoint boundary (rodent strength/cardiac vs human metabolic/inflammatory), not a within-hypothesis refutation.
2. Soften 'limited by Receipt 2' to language like 'does not automatically transfer to' or 'is not replicated in' to avoid implying Receipt 2 is a direct test of Receipt 1.
3. Clarify in the conclusion that the bounded alpha is about translation across species, endpoints, and modalities—not a universal benefit or failure claim.

Major issues

• The memo presents a 'split' between Receipt 1 (positive) and Receipt 2 (null for resveratrol, positive for exercise), but this is not a genuine contradiction—it is a species and modality difference (rats/strength+cardiac vs aged men/metabolic+inflammatory). Framing it as Receipt 1 being 'limited by Receipt 2' is a mild overclaim; the two receipts are simply different studies on different axes rather than one overturning the other.
• The title says 'resveratrol / exercise bounded update' but the actual bounded signal is more specifically that resveratrol effects seen in rodent strength/cardiac endpoints do not replicate in human metabolic/inflammatory endpoints. The boundedness is then muddied by not being explicit that this is essentially a species-translation boundary.

Minor issues

• The Receipt 2 excerpt is truncated mid-sentence ('3-hydrox' and 'inhibitor of κB'), reducing clarity.
• 'Receipt 1 axes' list 'exercise, training' redundantly with 'strength' and 'cardiac, performance, function'—axes could be tighter.
• The phrase 'looks positive in Receipt 1 but is limited by Receipt 2' implicitly treats Receipt 2 as a refutation rather than a different test, which slightly overstates the contrast.

Reviewer note

This is a competent alpha-memo that correctly identifies two genuinely paired receipts on resveratrol + exercise and honestly bounds the conclusion to a species/endpoint contrast. Source grounding is solid: both DOIs match real, well-cited studies (Menzies et al. 2012/2013 lineage), and the title/source alignment is correct. However, the memo mildly overclaims by framing the contrast as Receipt 1 being 'limited by' Receipt 2, when in fact these are two different studies on different axes (rats/strength+cardiac vs aged men/metabolic+inflammatory) rather than a direct replication attempt. The memo also correctly acknowledges this heterogeneity in its limitations section, but the framing in the abstract and one-sentence alpha leans slightly toward treating Receipt 2 as a falsifier of Receipt 1, which is not quite right. Revisions are bounded—mainly reframing the contrast as a translation boundary rather than a refutation. Scores: research_question 4, synthesis 3, claim_evidence_alignment 3, limitations 3, gaps 4, source_grounding 4.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis